First GLP-1 pill for obesity from Novo Nordisk launches in the U.S.
The drug's cash prices are among the lowest on the market, ranging from $149 to $299 per month, depending on the dose.
The drug's cash prices are among the lowest on the market, ranging from $149 to $299 per month, depending on the dose.
What's Your Reaction?
Economist Admin
Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.
